These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5062540)

  • 21. The effect of divalent metal cations on the inhibition of human coagulation factor Xa by plasma proteinase inhibitors.
    Ellis V; Scully M; Kakkar V
    Biochim Biophys Acta; 1983 Sep; 747(1-2):123-9. PubMed ID: 6192845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR; Lie M; Abildgaard U
    Haemostasis; 1976; 5(5):265-75. PubMed ID: 1017722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity.
    Choay J; Petitou M; Lormeau JC; Sinaÿ P; Casu B; Gatti G
    Biochem Biophys Res Commun; 1983 Oct; 116(2):492-9. PubMed ID: 6651824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active site of bovine factor Xa. Characterization using substituted benzamidines as competitive inhibitors and affinity-labeling reagents.
    Robison DJ; Furie B; Furie BC; Bing DH
    J Biol Chem; 1980 Mar; 255(5):2014-21. PubMed ID: 7354070
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors.
    Fuchs HE; Pizzo SV
    J Clin Invest; 1983 Dec; 72(6):2041-9. PubMed ID: 6196377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibition of activated bovine coagulation factors X and VII by antithrombin III.
    Jesty J
    Arch Biochem Biophys; 1978 Jan; 185(1):165-73. PubMed ID: 564164
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding of heparin in vitro and in vivo to plasma proteins.
    Marciniak E
    J Lab Clin Med; 1974 Sep; 84(3):344-56. PubMed ID: 4368450
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticoagulantly active heparin-like molecules from vascular tissue.
    Marcum JA; Rosenberg RD
    Biochemistry; 1984 Apr; 23(8):1730-7. PubMed ID: 6232950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of a catalytic role of heparin in anticoagulation reactions.
    Gitel SN
    Adv Exp Med Biol; 1975; 52():243-7. PubMed ID: 1124699
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for a naturally occurring plasma inhibitor of activated factor X: its isolation and partial purification.
    Yin ET; Wessler S
    Thromb Diath Haemorrh; 1969 Apr; 21(2):398-401. PubMed ID: 5769061
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemistry of the hemostatic mechanism and its relationship to the action of heparin.
    Rosenberg RD
    Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
    Ishida M; Nakada Y; Horiuchi M; Sakamoto F
    Arzneimittelforschung; 1998 Aug; 48(8):818-21. PubMed ID: 9748709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin, its fractions, fragments and derivatives. Some newer perspectives.
    Fareed J
    Semin Thromb Hemost; 1985 Jan; 11(1):1-9. PubMed ID: 3919446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permanent activation of antithrombin by covalent attachment of heparin oligosaccharides.
    Björk I; Larm O; Lindahl U; Nordling K; Riquelme ME
    FEBS Lett; 1982 Jun; 143(1):96-100. PubMed ID: 7117524
    [No Abstract]   [Full Text] [Related]  

  • 39. Bovine factor Xa and bovine trypsin: a comparison with respect to inhibition by some amidines and guanidines.
    Johnson VA; Smith RL
    Arch Biochem Biophys; 1976 Jul; 175(1):190-5. PubMed ID: 952518
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.